Toufik Bouhadiba, MD

Institut Curie
Paris, Ile-de-France, France

Disclosure information not submitted.

Presentation(s):

• Paper 38 - DEFINING NOVEL BENCHMARK VALUES FOR OUTCOMES OF COMPREHENSIVE RESECTION OF PRIMARY RETROPERITONEAL LIPOSARCOMA

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST